Albemarle Co. (NYSE:ALB)’s share price gapped down before the market opened on Friday after Jefferies Group lowered their price target on the stock to $150.00. The stock had previously closed at $138.70, but opened at $126.95. Jefferies Group currently has a buy rating on the stock. Albemarle shares last traded at $117.91, with a volume of 8622300 shares changing hands.
A number of other equities analysts have also weighed in on ALB. Loop Capital initiated coverage on shares of Albemarle in a research report on Thursday, September 28th. They set a “buy” rating and a $150.00 target price for the company. Oppenheimer reiterated a “buy” rating on shares of Albemarle in a research report on Wednesday. UBS Group increased their target price on shares of Albemarle from $123.00 to $150.00 and gave the stock a “neutral” rating in a research report on Thursday, November 9th. Royal Bank of Canada reiterated a “buy” rating and set a $149.00 target price on shares of Albemarle in a research report on Wednesday, October 18th. Finally, KeyCorp increased their target price on shares of Albemarle from $125.00 to $150.00 and gave the stock a “buy” rating in a research report on Monday, October 16th. Ten equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $127.78.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. State of Alaska Department of Revenue raised its stake in Albemarle by 69.5% in the fourth quarter. State of Alaska Department of Revenue now owns 16,942 shares of the specialty chemicals company’s stock valued at $2,165,000 after purchasing an additional 6,944 shares in the last quarter. McCollum Christoferson Group LLC purchased a new stake in Albemarle in the fourth quarter valued at approximately $2,844,000. Schwab Charles Investment Management Inc. raised its stake in Albemarle by 1.2% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 370,525 shares of the specialty chemicals company’s stock valued at $47,387,000 after purchasing an additional 4,547 shares in the last quarter. Creative Planning raised its stake in Albemarle by 70.9% in the fourth quarter. Creative Planning now owns 6,564 shares of the specialty chemicals company’s stock valued at $839,000 after purchasing an additional 2,723 shares in the last quarter. Finally, Bank of Montreal Can raised its stake in Albemarle by 64.7% in the fourth quarter. Bank of Montreal Can now owns 55,646 shares of the specialty chemicals company’s stock valued at $7,116,000 after purchasing an additional 21,869 shares in the last quarter. 88.07% of the stock is currently owned by institutional investors and hedge funds.
Albemarle (NYSE:ALB) last announced its earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.01. The business had revenue of $755.00 million for the quarter, compared to the consensus estimate of $732.19 million. Albemarle had a net margin of 30.07% and a return on equity of 11.61%. Albemarle’s quarterly revenue was up 15.4% on a year-over-year basis. During the same period last year, the firm posted $0.91 earnings per share. sell-side analysts expect that Albemarle Co. will post 4.46 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, January 2nd. Shareholders of record on Friday, December 15th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 1.09%. The ex-dividend date was Thursday, December 14th. Albemarle’s dividend payout ratio (DPR) is presently 45.71%.
ILLEGAL ACTIVITY WARNING: This article was reported by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another publication, it was stolen and republished in violation of US and international copyright legislation. The legal version of this article can be viewed at https://www.com-unik.info/2018/01/19/albemarle-alb-shares-gap-down-on-analyst-downgrade.html.
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.